Selection of the best of 2021 in vascular risk and cardiac rehabilitation
REC: CardioClinics
; 57:S29-S35, 2022.
Article
in English
| EMBASE | ID: covidwho-1676896
ABSTRACT
Cardiovascular disease is the leading cause of mortality. The COVID-19 pandemic has worsened the control of risk factors and has led to an increase in heart failure and infarction mortality. There is an urgent need to optimize prevention and cardiac rehabilitation. Fortunately, we have more efficient solutions than ever before. Prescribing lifestyle and physical exercise to all cardiovascular patients. Potent lipid-lowering drugs are already well established and others will be soon, there are new aspects to improve the control of arterial hypertension, and the new era in global diabetes protection is being consolidated. Cardiac rehabilitation is much more digital and at home and the new 2021 European cardiovascular prevention guidelines insist on primary prevention and new emerging risk factors.
Full text:
Available
Collection:
Databases of international organizations
Database:
EMBASE
Type of study:
Prognostic study
Language:
English
Journal:
REC: CardioClinics
Year:
2022
Document Type:
Article
Similar
MEDLINE
...
LILACS
LIS